Add BrightSurf on Google Email

Programmed cell death in cancer cells: Overcoming resistance through paraptosis-inducing compounds

Researchers from Tokyo University of Science developed novel complex-peptide hybrids that induce programmed cell death in apoptosis-resistant cancer cells through paraptosis. The compounds, syn-6 and anti-6, inhibit cell death by uncoupling mitochondrial calcium uptake and inducing cytoplasmic vacuolization, leading to cell death.

SourceTokyo University of Science·JournalBioconjugate Chemistry·TypeExperimental study·DateJul 11, 2022

App to help doctors help patients with leukemia

Researchers have developed an app to help doctors identify patients with chronic lymphocytic leukemia (CLL) at risk of developing infections, allowing for earlier treatment. The app uses blood test results and genetic data to predict patient risk, improving treatment outcomes and reducing pressure on the healthcare system.

SourceUniversity of Copenhagen - The Faculty of Health and Medical Sciences·JournalCommunications Medicine·TypeCase study·DateJun 24, 2022

Study at molecular level finds IRL green sea turtles biologically stressed

Research at Florida Atlantic University found that green sea turtles in polluted environments have impaired immune systems, leading to increased disease susceptibility. The study suggests a positive feedback loop where pollution compromises immunity, making turtles more prone to Green Turtle Fibropapillomatosis.

SourceFlorida Atlantic University·JournalJournal of Wildlife Diseases·TypeExperimental study·DateOct 12, 2021

Scientists discover a highly potent antibody against SARS-CoV-2

Researchers have identified a highly potent antibody that effectively blocks the spike protein of SARS-CoV-2, halting viral replication and enabling the immune system to eliminate the virus. This breakthrough discovery offers a potential preventive-treatment option for unvaccinated individuals or those with weakened immune systems.

SourceEcole Polytechnique Fédérale de Lausanne·JournalCell Reports·TypeExperimental study·DateOct 12, 2021

Adverse complications for covid positive pregnant women and their newborns adds further weight to vaccination calls

A new study found a significant increase in adverse outcomes for COVID-19 positive pregnant women, including gestational diabetes, low white blood cell counts, and heavier bleeding during delivery. Respiratory complications were also witnessed in their babies, highlighting the importance of vaccinating all pregnant women against COVID-19.

SourceTaylor & Francis Group·JournalThe Journal of Maternal-Fetal & Neonatal Medicine·DateOct 10, 2021

Adoptive transfer of tumor-infiltrating lymphocytes may be less effective in patients with pretreated metastatic melanoma

Patients with relapsed metastatic melanoma who received prior anti-PD-1 therapies had a lower response rate to adoptive cell transfer of tumor-infiltrating lymphocytes (ACT-TIL). ACT-TIL was less effective in these patients compared to those who had never received anti-PD-1 therapy. The study found that the objective response rate and ...

SourceAmerican Association for Cancer Research·JournalClinical Cancer Research·DateAug 19, 2021

How COVID-19 kills

A new study explains the mechanisms of COVID-19, revealing how the virus triggers an immune system overreaction, resulting in a cytokine storm. This can lead to respiratory failure, as well as damage to organs such as the heart and kidneys. Treatment focuses on managing symptoms and supporting organ function.

SourceFrontiers·JournalFrontiers in Public Health·DateMay 13, 2020

Platelets exacerbate immune response

A new study by the University of Bonn reveals that platelets exacerbate immune responses by activating inflammasomes and increasing IL-1 production. This finding has significant implications for treating autoimmune diseases such as rheumatism and diabetes.

SourceUniversity of Bonn·JournalCell Reports·DateMay 12, 2020

Impact of donor lymphocyte infusion and intensified conditioning for relapsed/refractory leukemia

A large cohort study found that donor lymphocyte infusion and intensified conditioning improve outcomes for patients with relapsed/refractory leukemia, achieving high 3-year leukemia-free survival rates. The study also showed that these interventions have varying impacts on different types of leukemia and donor recipients.

SourceScience China Press·JournalScience China Life Sciences·DateApr 15, 2020

To be or not to be a white blood cell, that is the question

Researchers discovered a mechanism that determines whether immature blood cells differentiate into red or subtypes of white blood cells. The study found that repression of Bach factors contributes to the development of anemia of infection/inflammation, highlighting potential therapeutic targets for treating bone marrow and blood disord...

SourceTohoku University·JournalNature Immunology·DateSep 25, 2018